Animal & Veterinary
Supplemental New Animal Drug Approvals - January/February 2002
FDA Veterinarian Newsletter January/February 2002 Volume XVII, No 1
| Company | Generic and (Brand) Names | Indications | Routes/Remarks |
|---|---|---|---|
| Schering-Plough Animal Health Corp. (NADA140-951) | Diclazuril (ClinacoxTM) | Turkeys. For prevention of coccidiosis. | MEDICATED FEED—The supplemental NADA provides for use of the approved diclazuril Type A medicated article to make Type B and Type C medicated turkey feeds used for prevention of coccidiosis caused by Eimeria adenoeides, E. gallopavonis, and E. melagrimitis. Also, the NADA establishes tolerances for diclazuril residues in turkey liver at 3 ppm, muscle at 0.5 ppm, and skin with adherent fat at 1 ppm. Federal Register 12/04/01 |
| Pfizer, Inc. (NADA 141-053) | Carprofen (Rimadyl® Caplets) Rx | Dogs. For the relief of pain and inflammation associated with osteoarthritis. | ORAL—The supplement provides for a once daily, 2 mg/lb dosage of carprofen, by oral caplet. Federal Register 12/05/01 |
| MoorMan's, Inc. (NADA 115-581) | Monensin (MoorMan's Mintrate Blonde Block RU and MoorMan's Mintrate Red Block RU) | Cattle. For prevention and control of coccidiosis. | MEDICATED FEED—The supplement provides for use of approved monensin Type A medicated articles to make free-choice, medicated feed blocks used for prevention and control of coccidiosis caused by Eimeria bovis and E. zuernii in pasture cattle. Federal Register 12/07/01 |
